Tel: +86 (0)571 8102-5280 Email: sales@molcore.com
1003019-41-7 | GNF362

GNF362 NLT 98%

Product Number : MC500545

CAS Number : 1003019-41-7

Molecular Formula : C22H21F3N6 | Molecular Weight : 426.44

Quote Request
Purity NLT 98%
Storage at 20ºC 2 years
MolCore specializes in manufacturing high-purity CAS No.1003019-41-7, GNF362 with the molecular formula C22H21F3N6 and molecular weight 426.44 delivering critical API intermediates for global pharmaceutical and research industries, certified under ISO quality systems.

* The above information is for reference only.

Chemical Name GNF362
CAS Number 1003019-41-7
Molecular Formula C22H21F3N6
Molecular Weight 426.44
Introduction of 1003019-41-7 :

GNF362 is a selective, potent, and orally bioavailable inhibitor of inositol trisphosphate 3’ kinase B (Itpkb) with an IC50 of 9 nM. GNF362 also inhibits Itpka and Itpkc with IC50 values of 20 nM and 19 nM, respectively. Inositol trisphosphate 3’ kinase B (Itpkb) is a Ca2+-dependent kinase, which phosphorylates the 3’ position of Ins (1,4,5) P3 to generate inositol 1,3,4,5-tetrakisphosphate [Ins (1,3,4,5) P4][1]. In Vitro: GNF362 (0-10 mM) blocks Ins (1,3,4,5) P4 production, enhances antigen receptor-driven Ca2+ responses and lead to apoptosis of activated T cells in an Itpkb-dependent manner in lymphocytes[1].
GNF362 augments SOC responses following antigen receptor cross-linking, with an EC50 of 12 nM in primary B or T lymphocytes[1].
In Vivo: GNF362 (orally administration; 6 or 20 mg/kg; twice daily; 21 days) shows minimal block in antibody production but shows significant inhibition of joint swelling at 6 mg/kg, reduces inflammatory cell infiltrate, joint damage, and proteoglycan loss at 20 mg/kg[1].